Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined 18F-FDG and 18F-FLT PET/CT imaging.
Christos SachpekidisH GoldschmidtK KopkaA Kopp-SchneiderA Dimitrakopoulou-StraussPublished in: EJNMMI research (2018)
Despite the limited number of patients analyzed in this pilot study, the first results of the trial indicate that 18F-FLT does not seem suitable as a single tracer in MM diagnostics. Further studies with a larger patient population are warranted to generalize the herein presented results.
Keyphrases
- pet ct
- positron emission tomography
- acute myeloid leukemia
- end stage renal disease
- multiple myeloma
- newly diagnosed
- tyrosine kinase
- ejection fraction
- pet imaging
- chronic kidney disease
- clinical trial
- peritoneal dialysis
- signaling pathway
- study protocol
- computed tomography
- prognostic factors
- randomized controlled trial
- mass spectrometry
- patient reported
- fluorescence imaging
- clinical evaluation